EV/Assets Ratio: 1.78x
Is the EV/Assets ratio high or low?
The EV/Assets ratio of 1.78x is 13% above its 5-year average of 1.58x, near the high end of its 5-year range (1.34x–1.88x).
As of Friday, June 26, 2026. 5.89% above its 12-month average of 1.68x.
DGX EV/Assets Ratio Chart
DGX Average EV/Assets Ratio Chart
DGX Current vs Average EV/Assets Ratio Chart
DGX EV/Assets Ratio Metrics
EV/ASSETS RATIO
1.78x
EV/ASSETS RATIO AVG TTM
1.68x
EV/ASSETS RATIO AVG 3Y
1.57x
EV/ASSETS RATIO AVG 5Y
1.58x
EV/ASSETS RATIO AVG 10Y
1.58x
EV/ASSETS RATIO AVG 15Y
1.51x
EV/ASSETS RATIO AVG 20Y
1.51x
CURRENT VS TTM AVG
+5.89%
CURRENT VS 3Y AVG
+13.59%
CURRENT VS 5Y AVG
+12.91%
CURRENT VS 10Y AVG
+12.53%
CURRENT VS 15Y AVG
+18.14%
CURRENT VS 20Y AVG
+17.70%
DGX Competitors' EV/Assets Ratio
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quest Diagnostics Incorporated (DGX) | $23.08B | 1.78x | 1.68x | 1.57x | 1.58x |
| BioNTech SE (BNTX)vs › | $23.07B | 0.49x | 0.54x | 0.54x | 1.29x |
| United Therapeutics Corporation (UTHR)vs › | $23.03B | 3.65x | 2.76x | 2.19x | 2.08x |
| Incyte Corporation (INCY)vs › | $22.73B | 2.74x | 2.53x | 2.15x | 2.46x |
| Labcorp Holdings Inc. (LH)vs › | $22.10B | 1.48x | 1.57x | 1.46x | 1.38x |
| Waters Corporation (WAT)vs › | $24.41B | 1.46x | 3.98x | 4.50x | 5.42x |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.79B | 6.13x | 4.70x | 5.88x | 6.71x |
| STERIS plc (STE)vs › | $21.00B | 2.08x | 2.41x | 2.36x | 2.28x |
| Mettler-Toledo International Inc. (MTD)vs › | $25.44B | 7.47x | 8.22x | 8.60x | 9.30x |
| Moderna, Inc. (MRNA)vs › | $26.35B | 2.00x | 1.19x | 1.48x | 2.49x |
EV/Assets Ratio Formula & Definition
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
EV/Assets Ratio FAQ
- What is the EV/Assets ratio for Quest Diagnostics Incorporated (DGX)?
- The EV/Assets ratio for DGX stock is 1.78x.
- Is Quest Diagnostics Incorporated's EV/Assets ratio high or low?
- The EV/Assets ratio of 1.78x is 13% above its 5-year average of 1.58x, near the high end of its 5-year range (1.34x–1.88x).
- What is the TTM average EV/Assets ratio for Quest Diagnostics Incorporated (DGX)?
- The TTM average EV/Assets ratio for DGX stock is 1.68x.
- What is the 3Y average EV/Assets ratio for Quest Diagnostics Incorporated (DGX)?
- The 3Y average EV/Assets ratio for DGX stock is 1.57x.
- What is the 5Y average EV/Assets ratio for Quest Diagnostics Incorporated (DGX)?
- The 5Y average EV/Assets ratio for DGX stock is 1.58x.
- What is the 10Y average EV/Assets ratio for Quest Diagnostics Incorporated (DGX)?
- The 10Y average EV/Assets ratio for DGX stock is 1.58x.
- What is the 15Y average EV/Assets ratio for Quest Diagnostics Incorporated (DGX)?
- The 15Y average EV/Assets ratio for DGX stock is 1.51x.
- What is the 20Y average EV/Assets ratio for Quest Diagnostics Incorporated (DGX)?
- The 20Y average EV/Assets ratio for DGX stock is 1.51x.
DGX EV/Assets Ratio History
| DATE | EV/ASSETS RATIO |
|---|---|
| 2026-06-25 | 1.78x |
| 2026-06-24 | 1.76x |
| 2026-06-23 | 1.72x |
| 2026-06-22 | 1.70x |
| 2026-06-18 | 1.70x |
| 2026-06-17 | 1.72x |
| 2026-06-16 | 1.75x |
| 2026-06-15 | 1.75x |
| 2026-06-12 | 1.76x |
| 2026-06-11 | 1.76x |
| 2026-06-10 | 1.76x |
| 2026-06-09 | 1.77x |
| 2026-06-08 | 1.72x |
| 2026-06-05 | 1.74x |
| 2026-06-04 | 1.71x |
| 2026-06-03 | 1.70x |
| 2026-06-02 | 1.69x |
| 2026-06-01 | 1.69x |
| 2026-05-29 | 1.70x |
| 2026-05-28 | 1.71x |
| 2026-05-27 | 1.70x |
| 2026-05-26 | 1.69x |
| 2026-05-22 | 1.71x |
| 2026-05-21 | 1.70x |
| 2026-05-20 | 1.70x |
| 2026-05-19 | 1.67x |
| 2026-05-18 | 1.67x |
| 2026-05-15 | 1.65x |
| 2026-05-14 | 1.66x |
| 2026-05-13 | 1.68x |
| 2026-05-12 | 1.67x |
| 2026-05-11 | 1.67x |
| 2026-05-08 | 1.65x |
| 2026-05-07 | 1.68x |
| 2026-05-06 | 1.67x |
| 2026-05-05 | 1.68x |
| 2026-05-04 | 1.68x |
| 2026-05-01 | 1.69x |
| 2026-04-30 | 1.70x |
| 2026-04-29 | 1.67x |
| 2026-04-28 | 1.71x |
| 2026-04-27 | 1.72x |
| 2026-04-24 | 1.71x |
| 2026-04-23 | 1.74x |
| 2026-04-22 | 1.77x |
| 2026-04-21 | 1.82x |
| 2026-04-20 | 1.76x |
| 2026-04-17 | 1.75x |
| 2026-04-16 | 1.72x |
| 2026-04-15 | 1.72x |
| 2026-04-14 | 1.74x |
| 2026-04-13 | 1.73x |
| 2026-04-10 | 1.72x |
| 2026-04-09 | 1.77x |
| 2026-04-08 | 1.77x |
| 2026-04-07 | 1.76x |
| 2026-04-06 | 1.77x |
| 2026-04-02 | 1.77x |
| 2026-04-01 | 1.77x |
| 2026-03-31 | 1.75x |
| 2026-03-30 | 1.76x |
| 2026-03-27 | 1.75x |
| 2026-03-26 | 1.77x |
| 2026-03-25 | 1.76x |
| 2026-03-24 | 1.75x |
| 2026-03-23 | 1.75x |
| 2026-03-20 | 1.75x |
| 2026-03-19 | 1.74x |
| 2026-03-18 | 1.75x |
| 2026-03-17 | 1.77x |
| 2026-03-16 | 1.77x |
| 2026-03-13 | 1.78x |
| 2026-03-12 | 1.79x |
| 2026-03-11 | 1.79x |
| 2026-03-10 | 1.79x |
| 2026-03-09 | 1.79x |
| 2026-03-06 | 1.78x |
| 2026-03-05 | 1.81x |
| 2026-03-04 | 1.84x |
| 2026-03-03 | 1.84x |
| 2026-03-02 | 1.85x |
| 2026-02-27 | 1.86x |
| 2026-02-26 | 1.86x |
| 2026-02-25 | 1.82x |
| 2026-02-24 | 1.83x |
| 2026-02-23 | 1.81x |
| 2026-02-20 | 1.78x |
| 2026-02-19 | 1.78x |
| 2026-02-18 | 1.79x |
| 2026-02-17 | 1.80x |
| 2026-02-13 | 1.81x |
| 2026-02-12 | 1.81x |
| 2026-02-11 | 1.83x |
| 2026-02-10 | 1.80x |
| 2026-02-09 | 1.70x |
| 2026-02-06 | 1.70x |
| 2026-02-05 | 1.71x |
| 2026-02-04 | 1.69x |
| 2026-02-03 | 1.66x |
| 2026-02-02 | 1.66x |
| 2026-01-30 | 1.67x |
| 2026-01-29 | 1.64x |
| 2026-01-28 | 1.64x |
| 2026-01-27 | 1.65x |
| 2026-01-26 | 1.64x |
| 2026-01-23 | 1.63x |
| 2026-01-22 | 1.64x |
| 2026-01-21 | 1.66x |
| 2026-01-20 | 1.69x |
| 2026-01-16 | 1.69x |
| 2026-01-15 | 1.69x |
| 2026-01-14 | 1.67x |
| 2026-01-13 | 1.62x |
| 2026-01-12 | 1.59x |
| 2026-01-09 | 1.58x |
| 2026-01-08 | 1.61x |
| 2026-01-07 | 1.61x |
| 2026-01-06 | 1.63x |
| 2026-01-05 | 1.58x |
| 2026-01-02 | 1.58x |
| 2025-12-31 | 1.58x |
| 2025-12-30 | 1.59x |
| 2025-12-29 | 1.59x |
| 2025-12-26 | 1.59x |
| 2025-12-24 | 1.59x |
| 2025-12-23 | 1.59x |
| 2025-12-22 | 1.60x |
| 2025-12-19 | 1.60x |
| 2025-12-18 | 1.60x |
| 2025-12-17 | 1.62x |
| 2025-12-16 | 1.61x |
| 2025-12-15 | 1.65x |
| 2025-12-12 | 1.64x |
| 2025-12-11 | 1.63x |
| 2025-12-10 | 1.62x |
| 2025-12-09 | 1.62x |
| 2025-12-08 | 1.64x |
| 2025-12-05 | 1.64x |
| 2025-12-04 | 1.65x |
| 2025-12-03 | 1.64x |
| 2025-12-02 | 1.64x |
| 2025-12-01 | 1.65x |
| 2025-11-28 | 1.69x |
| 2025-11-26 | 1.69x |
| 2025-11-25 | 1.71x |
| 2025-11-24 | 1.70x |
| 2025-11-21 | 1.70x |
| 2025-11-20 | 1.68x |
| 2025-11-19 | 1.66x |
| 2025-11-18 | 1.66x |
| 2025-11-17 | 1.67x |
| 2025-11-14 | 1.67x |
| 2025-11-13 | 1.68x |
| 2025-11-12 | 1.67x |
| 2025-11-11 | 1.68x |
| 2025-11-10 | 1.65x |
| 2025-11-07 | 1.62x |
| 2025-11-06 | 1.60x |
| 2025-11-05 | 1.61x |
| 2025-11-04 | 1.61x |
| 2025-11-03 | 1.62x |
| 2025-10-31 | 1.59x |
| 2025-10-30 | 1.59x |
| 2025-10-29 | 1.59x |
| 2025-10-28 | 1.61x |
| 2025-10-27 | 1.62x |
| 2025-10-24 | 1.64x |
| 2025-10-23 | 1.65x |
| 2025-10-22 | 1.63x |
| 2025-10-21 | 1.66x |
| 2025-10-20 | 1.73x |
| 2025-10-17 | 1.72x |
| 2025-10-16 | 1.70x |
| 2025-10-15 | 1.71x |
| 2025-10-14 | 1.69x |
| 2025-10-13 | 1.67x |
| 2025-10-10 | 1.68x |
| 2025-10-09 | 1.66x |
| 2025-10-08 | 1.66x |
| 2025-10-07 | 1.67x |
| 2025-10-06 | 1.64x |
| 2025-10-03 | 1.65x |
| 2025-10-02 | 1.66x |
| 2025-10-01 | 1.67x |
| 2025-09-30 | 1.73x |
| 2025-09-29 | 1.72x |
| 2025-09-26 | 1.72x |
| 2025-09-25 | 1.69x |
| 2025-09-24 | 1.70x |
| 2025-09-23 | 1.70x |
| 2025-09-22 | 1.69x |
| 2025-09-19 | 1.68x |
| 2025-09-18 | 1.68x |
| 2025-09-17 | 1.67x |
| 2025-09-16 | 1.65x |
| 2025-09-15 | 1.66x |
| 2025-09-12 | 1.67x |
| 2025-09-11 | 1.68x |
| 2025-09-10 | 1.65x |
| 2025-09-09 | 1.67x |
| 2025-09-08 | 1.67x |
| 2025-09-05 | 1.68x |
| 2025-09-04 | 1.65x |
| 2025-09-03 | 1.65x |
| 2025-09-02 | 1.64x |
| 2025-08-29 | 1.67x |
| 2025-08-28 | 1.65x |
| 2025-08-27 | 1.65x |
| 2025-08-26 | 1.66x |
| 2025-08-25 | 1.64x |
| 2025-08-22 | 1.66x |
| 2025-08-21 | 1.68x |
| 2025-08-20 | 1.68x |
| 2025-08-19 | 1.67x |
| 2025-08-18 | 1.65x |
| 2025-08-15 | 1.65x |
| 2025-08-14 | 1.64x |
| 2025-08-13 | 1.65x |
| 2025-08-12 | 1.64x |
| 2025-08-11 | 1.64x |
| 2025-08-08 | 1.63x |
| 2025-08-07 | 1.61x |
| 2025-08-06 | 1.60x |
| 2025-08-05 | 1.61x |
| 2025-08-04 | 1.60x |
| 2025-08-01 | 1.59x |
| 2025-07-31 | 1.56x |
| 2025-07-30 | 1.57x |
| 2025-07-29 | 1.57x |
| 2025-07-28 | 1.57x |
| 2025-07-25 | 1.57x |
| 2025-07-24 | 1.60x |
| 2025-07-23 | 1.59x |
| 2025-07-22 | 1.68x |
| 2025-07-21 | 1.59x |
| 2025-07-18 | 1.60x |
| 2025-07-17 | 1.61x |
| 2025-07-16 | 1.60x |
| 2025-07-15 | 1.59x |
| 2025-07-14 | 1.61x |
| 2025-07-11 | 1.61x |
| 2025-07-10 | 1.63x |
| 2025-07-09 | 1.65x |
| 2025-07-08 | 1.64x |
| 2025-07-07 | 1.65x |
| 2025-07-03 | 1.67x |
| 2025-07-02 | 1.67x |
| 2025-07-01 | 1.69x |
| 2025-06-30 | 1.69x |
| 2025-06-27 | 1.68x |
| 2025-06-26 | 1.67x |
| 2025-06-25 | 1.68x |
| 2025-06-24 | 1.69x |
| 2025-06-23 | 1.69x |
| 2025-06-20 | 1.69x |
| 2025-06-18 | 1.69x |
| 2025-06-17 | 1.68x |
| 2025-06-16 | 1.71x |
| 2025-06-13 | 1.69x |
| 2025-06-12 | 1.68x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- James E. Davis